TY - JOUR
T1 - Non-Pharmacological Components in Integrated Treatment for Patients with Dual Diagnosis
T2 - A Scoping Review
AU - Düring, Signe Wegmann
AU - Sivertsen, Ditte Maria
AU - Johansen, Katrine Schepelern
PY - 2025/4/3
Y1 - 2025/4/3
N2 - Objective: To examine how non-pharmacological integrated treatment components are presented in the literature, to facilitate high-quality dual diagnosis treatment and support informed decision-making in the development of integrated treatment facilities. Methods: A literature search was conducted in databases Ovid/Embase, PubMed, CINAHL focusing on intervention studies published between 2013 and 2023, describing integrated treatment for patients with dual diagnosis. A six-stage methodological framework for scoping reviews was used for selection and analysis of the papers included. Results: Twenty-six studies were included. Most integrated interventions were group therapy sessions guided by CBT or MI, however there was a large heterogeneity in the remaining core components and outcome measurements. Staff competence was often vaguely defined and described. Conclusions: The heterogeneity of the studies included influences reproductivity and comparability which makes it challenging to condense firm recommendations and point directions for design of treatment and scientific practice.
AB - Objective: To examine how non-pharmacological integrated treatment components are presented in the literature, to facilitate high-quality dual diagnosis treatment and support informed decision-making in the development of integrated treatment facilities. Methods: A literature search was conducted in databases Ovid/Embase, PubMed, CINAHL focusing on intervention studies published between 2013 and 2023, describing integrated treatment for patients with dual diagnosis. A six-stage methodological framework for scoping reviews was used for selection and analysis of the papers included. Results: Twenty-six studies were included. Most integrated interventions were group therapy sessions guided by CBT or MI, however there was a large heterogeneity in the remaining core components and outcome measurements. Staff competence was often vaguely defined and described. Conclusions: The heterogeneity of the studies included influences reproductivity and comparability which makes it challenging to condense firm recommendations and point directions for design of treatment and scientific practice.
KW - Humans
KW - Diagnosis, Dual (Psychiatry)
KW - Mental Disorders/therapy
KW - Substance-Related Disorders/therapy
KW - Cognitive Behavioral Therapy/methods
KW - Dual diagnosis
KW - Psychosis
KW - Substance use
KW - Integrated treatment
KW - Non-pharmacological
KW - Psychiatry
U2 - 10.1080/15504263.2025.2478900
DO - 10.1080/15504263.2025.2478900
M3 - Review
C2 - 40112128
SN - 1550-4263
VL - 21
SP - 120
EP - 141
JO - Journal of Dual Diagnosis
JF - Journal of Dual Diagnosis
IS - 2
ER -